Výsledky vyhledávání - "Dirk d'hooge"

Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results

Autor: Dirk D’Hooge, Laurent Crenier, Frank Nobels

Publikováno v: Current Medical Research and Opinion. 28:1017-1026

To investigate the safety and efficacy of switching to biphasic insulin aspart (BIAsp) 30, 50 or 70 in patients with type 2 diabetes previously treated with biphasic human insulin (BHI) 30/50 (with or without oral glucose-lowering drugs) in routine c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e394778e9f8910a82486a0f70e1e2f9b
https://doi.org/10.1185/03007995.2012.695730

Zobrazit plný text záznamu

Switch from metformin monotherapy to bitherapy with metformin and repaglinide to achieve glycated haemoglobin target in type 2 diabetes (REPAMET Study)

Autor: Dirk D’Hooge, Michel P. Hermans

Publikováno v: Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 3:224-227

Aim To evaluate glycaemic control, including HbA1c, following the addition of repaglinide to monotherapy with metformin as part of routine follow-up of adult type 2 diabetes patients no longer controlled with metformin (i.e. in secondary monotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8157aa9af22a465ebc9216e729d3d6be
https://doi.org/10.1016/j.dsx.2009.07.003

Zobrazit plný text záznamu

ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza®) in type 2 diabetic patients

Autor: Martin, Buysschaert, Dirk, D'Hooge, Vanessa, Preumont, John, Yango atoka Lofunge

Publikováno v: Diabetesmetabolic syndrome. 9(3)

The ROOTS study was an observational study to evaluate the effectiveness and safety of liraglutide (Victoza(®)), a GLP-1 receptor analog, in a cohort of patients with type 2 diabetes with inadequate glycaemic control despite conventional antihypergl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a29a2440773db896609f7e5b7956389
https://pubmed.ncbi.nlm.nih.gov/26004030

Zobrazit plný text záznamu

Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine. A double-blind, placebo-controlled study in young healthy volunteers

Autor: J Douchamps, Eric Delcourt, André Herchuelz, Claire Dulcire, Michèle Juvent, Dirk d'hooge, Willy Kostucki

Publikováno v: Clinical neuropharmacology. 13(1)

In a double-blind, placebo-controlled, crossover study, the effects of therapeutic doses of the new tricyclic antidepressant tianeptine on cardiovascular function were closely monitored in 21 healthy volunteers during a 2-week treatment period. Blood

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a4fe72e828821b1de4d65dd7d5324f
https://pubmed.ncbi.nlm.nih.gov/2306747

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání